Sign in
Taking peopleNo phase

Looking for factors that predict outcomes in pituitary tumors after surgery

Collects patient data to build a prognosis classification for pituitary tumors after surgery.

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
A Twenty-years' Experience in Pituitary Disease.
Status
Recruiting
People taking part
1,600 people, planned
Started
10 Mar 2025
Expected to end
30 Apr 2028
Type of study
Observational
Treatments tested
  • Frequency of disease recurrence
Record updated
15 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who had surgery to remove a pituitary tumor. Their data will be studied to find signs that predict how the disease goes.

Age
Older than 18 years at diagnosis of the pituitary tumor.
Sex
All sexes can join.
Disease stage
A pituitary tumor confirmed by a lab exam of the tissue (pathology diagnosis).
Earlier treatment
People must have had surgery for the pituitary tumor.

Main reasons for not taking part

  • Age lower than 18 years
  • Follow-up shorter than 2 years

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients underwent surgery for pituitary tumors
  • pathology diagnosis of pituitary tumors
  • patients older then 18 years at diagnosis of pituitary tumors
  • 2 years follow-up

Who cannot take part

  • age lower then 18 years
  • follow-up shorter than 2 years

This trial is currently available in Italy.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Pituitary tumors represent a heterogeneous group of neoplasms by histotype. The pituitary adenomas are the most frequent heteroformation, among those affecting the pituitary gland, followed by meningiomas, craniopharyngiomas, germosomes and tumours secondary, such as metastases and lymphomas. Since these conditions are considered rare, the data epidemiology and prognosis to predict the natural history of these diseases can not be considered conclusive. Pituitary adenomas are a useful model for epidemiology in the study of pathology pituitary. Over the past 20 years, several attempts have been made to identify unique prognostic factors, which predict the outcome of these pathologies, but without To arrive at a definitive classification. The purpose of this study aims to collect clinical, biochemical, morphological and pathological data on the retrospective and prospective cohort of over 1600 patients undergoing neurosurgical removal of pituitary tumors in the last 20 years, to develop a prognostic classification.

The group in the trial

  • Patients with pituitary tumors

    Patients with pituitary tumors, underwent surgical resection

    Treatment: Frequency of disease recurrence

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Twenty-years' Experience in Pituitary Disease: Identification of Prognostic Factors in Pituitary Tumors
Plain-language title
Looking for factors that predict outcomes in pituitary tumors after surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
15 May 2025